Hostname: page-component-745bb68f8f-grxwn Total loading time: 0 Render date: 2025-01-11T09:01:36.774Z Has data issue: false hasContentIssue false
  • English
  • Français

Canadian Guidelines for the Development of Antidementia Therapies: 2nd Canadian Conference on Antidementia Drug Guidelines

Published online by Cambridge University Press:  02 December 2014

Howard H. Feldman
Howard H. Feldman*
Affiliation:
Division of Neurology, University of British Columbia, Vancouver, BC, Canada
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Other
Information
Canadian Journal of Neurological Sciences , Volume 34 , Issue S1 , March 2007 , pp. i - S2
Copyright
Copyright © The Canadian Journal of Neurological 2007

References

1. Feldman, HH, Gauthier, S, Chertkow, H, Conn, DK, Freedman, M, MacKnight, C. on behalf of the 2nd Canadian Conference on Antidementia Guidelines Committee. Canadian Guidelines for the Development of Antidementia Therapies: a conceptual summary. Can J Neurol Sci. 2006; 33(1): 6–26.CrossRefGoogle Scholar